CCR4 and primary cutaneous T-cell non-Hodgkin lymphoma: The high-resolution structures provided in this study would also provide helpful information for the design of improved CCR4-targeting therapeutics and effective combination therapies to overcome mogamulizumab resistance for the treatment of CTCL.